60343-28-4

Basic information

• Product Name: Pentanoic acid, 5-bromo-, phenylmethyl ester
• CAS NO: 60343-28-4
• Molecular Formula: C12H15BrO2
• Molecular Weight: 271.154
• Mol File: 60343-28-4.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: Pentanoic acid, 5-bromo-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Pentanoic acid, 5-bromo-, phenylmethyl ester(60343-28-4)
• EPA Substance Registry System: Pentanoic acid, 5-bromo-, phenylmethyl ester(60343-28-4)

Safety Data

• Hazardous Substances Data: 60343-28-4(Hazardous Substances Data)

Upstream product

• 2067-33-6 5-bromopentanoic acid 
• 100-51-6 benzyl alcohol 
• 501-53-1 benzyl chloroformate 
• 4509-90-4 5-bromovaleroyl chloride 
• 1927-62-4 tetrahydro-2-(benzyloxy)-2H-pyran 

Downstream Products

• 219992-92-4 tris<4-(benzyloxycarbonyl)butyl>isocyanurate 
• 949166-57-8 benzyl 5-(diisopropyl phosphono)pentanoate 
• 5650-84-0 5-phosphonopentanoic acid 
• 854531-26-3 C₅₇H₆₀O₁₀ 
• 854531-31-0 C₅₉H₆₄O₁₀ 
• 286955-42-8 benzyl 5-(1,3-Dioxoisoindolin-2-yl)valerate 
• 1552321-94-4 4-(benzyloxycarbonyl)butyl 5-(Cbz-amino)-4-oxopentanoate 

Relevant articles and documents

Cationic Lipid

The present invention provides a cationic lipid which is able to be used for nucleic acid delivery to the cytoplasm. A cationic lipid according to the present invention is, for example, a compound represented by formula (1) or a pharmaceutically acceptable salt thereof, wherein L1 and L2 independently represent an alkylene group having 3 to 10 carbon atoms; R1 and R2 independently represent an alkyl group having 4 to 24 carbon atoms or an alkenyl group having 4 to 24 carbon atoms; R3 represents an alkyl group having 1 to 3 carbon atoms; and X1 represents a single bond or CO—O—.

COMPOUNDS

The invention relates to new derivatives of 5-aminolevulinic acid (5-ALA) and their use as photosensitizing agents. In particular, it relates to compounds of general formula I and their pharmaceutically acceptable salts, to methods for preparing such compounds and their medical and cosmetic use, for example in methods of photodynamic therapy and diagnosis: wherein R1 represents a hydrogen atom or an optionally substituted alkyl or cycloalkyl group; R2, each of which may be the same or different, represents a hydrogen atom or an optionally substituted alkyl group; and X is a linking group.

Supramolecular architectures from bent-core dendritic molecules

Control of the self-assembly of small molecules to generate architectures with diverse shapes and dimensions is a challenging research field. We report unprecedented results on the ability of ionic, bent dendritic molecules to aggregate in water. A range of analytical techniques (TEM, SEM, SAED, and XRD) provide evidence of the formation of rods, spheres, fibers, helical ribbons, or tubules from achiral molecules. The compact packing of the bent-core structures, which promotes the bent-core mesophases, also occurs in the presence of a poor solvent to provide products ranging from single objects to supramolecular gels. The subtle balance of molecule/solvent interactions and appropriate molecular designs also allows the transfer of molecular conformational chirality to morphological chirality in the overall superstructure. Functional motifs and controlled morphologies can be combined, thereby opening up new prospects for the generation of nanostructured materials through a bottom-up strategy.